Back

ApoC-III targeting: a new era in triglyceride management

28 August 2026 (15:27 - 15:37)
Organised by: Logo
Congress Presentation Part of: ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG) Lipids, Metabolism Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sybil Charriere

Hospital Louis Pradel of Bron, Bron (France)

4 More presentations in this session

Presentation thumbnail
Welcome and agenda
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
Triglycerides: a cardiologists’ concern – what are the risks?
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
How I manage my patients with sHTG
Associate Professor T. Stulnig (Vienna, AT)
Presentation thumbnail
Q&A, panel discussion and closing remarks

Access the full session

Session thumbnail
ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG)

The Event

Event poster

ESC Congress 2026

28 August 2026 15:27 CET
You may be interested in
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Welcome & introduction
29 August 2025
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021
thumbnail
Congress Presentation
Lowering apolipoprotein C-III associates with regression of lipidic plaque materials in type 2 DM patients with coronary artery disease: the pre-specified analysis from the OPTIMAL trial
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources